Biomarker modulation in patients (pts) receiving TRC105 (T) and bevacizumab (B) in a phase Ib clinical trial.

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Liu, Y; Clarke, JM; Starr, MD; Brady, JC; Pang, H; Rushing, C; Alvarez, D; Adams, BJ; Theuer, CP; Hurwitz, H; Nixon, AB

Published Date

  • May 20, 2014

Published In

Volume / Issue

  • 32 / 15_suppl

Start / End Page

  • 11020 - 11020

Published By

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Digital Object Identifier (DOI)

  • 10.1200/jco.2014.32.15_suppl.11020